Sanofi (LON: 0A2V)
London flag London · Delayed Price · Currency is GBP · Price in USD
54.00
-0.60 (-1.10%)
At close: Jan 31, 2025

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of GBP 108.93 billion. The enterprise value is 117.98 billion.

Market Cap 108.93B
Enterprise Value 117.98B

Important Dates

The last earnings date was Thursday, January 30, 2025.

Earnings Date Jan 30, 2025
Ex-Dividend Date May 9, 2024

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.40%
Shares Change (QoQ) +0.05%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.10B

Valuation Ratios

The trailing PE ratio is 22.93.

PE Ratio 22.93
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 11.52
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 24.84
EV / Sales 3.19
EV / EBITDA 11.34
EV / EBIT 15.46
EV / FCF n/a

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.

Current Ratio 1.46
Quick Ratio 0.28
Debt / Equity 0.23
Debt / EBITDA 1.45
Debt / FCF n/a
Interest Coverage 8.45

Financial Efficiency

Return on equity (ROE) is 7.53% and return on invested capital (ROIC) is 6.01%.

Return on Equity (ROE) 7.53%
Return on Assets (ROA) 4.37%
Return on Invested Capital (ROIC) 6.01%
Return on Capital Employed (ROCE) 8.73%
Revenue Per Employee 425,416
Profits Per Employee 55,177
Employee Count 86,088
Asset Turnover 0.34
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +7.38% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +7.38%
50-Day Moving Average 49.15
200-Day Moving Average 51.29
Relative Strength Index (RSI) 69.38
Average Volume (20 Days) 9,837

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Sanofi had revenue of GBP 36.62 billion and earned 4.75 billion in profits. Earnings per share was 3.80.

Revenue 36.62B
Gross Profit 25.70B
Operating Income 7.50B
Pretax Income 5.79B
Net Income 4.75B
EBITDA 10.24B
EBIT 7.50B
Earnings Per Share (EPS) 3.80
Full Income Statement

Balance Sheet

The company has 6.15 billion in cash and 14.81 billion in debt, giving a net cash position of -8.65 billion.

Cash & Cash Equivalents 6.15B
Total Debt 14.81B
Net Cash -8.65B
Net Cash Per Share n/a
Equity (Book Value) 64.54B
Book Value Per Share 51.25
Working Capital 11.10B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 70.18%, with operating and profit margins of 20.48% and 12.97%.

Gross Margin 70.18%
Operating Margin 20.48%
Pretax Margin 15.80%
Profit Margin 12.97%
EBITDA Margin 27.97%
EBIT Margin 20.48%
FCF Margin n/a

Dividends & Yields

Sanofi does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) 6.57%
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield 0.40%
Shareholder Yield 0.40%
Earnings Yield 4.36%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a